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Abstract 
Review on aquaporin-2 (AQP2), with data on DNA, 
on the protein encoded, and where the gene is 
implicated. 
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Identity 
Other names: AQP-CD, WCH-CD 
HGNC (Hugo): AQP2 
Location : 12q13 
DNA/RNA 
Transcription 
There are various splicing forms. Canonical form 
transcript (hg38), including UTRs: 
chr12:30,911,694 - 30,925,516, size: 13,823bp on 
forward (+) strand; coding region: chr12: 
49,950,746-49,958,881 size: 8,136bp, according to 
UCSC.  
Four exons: exon1 (nt 1 - 450) codes for amino acids 
(aa) 1-120, exon2 (nt 3415 - 3579) for aa 121-175; 
exon3 (nt 3890 - 3970) for aa 176-202, and exon4 (nt 
4659 - 8141)  for aa 203-271 (nextProt). 
Protein 
Aquaporins are a family of hydrophobic 
transmembrane channel proteins involved in 
transport of water and small molecules in response 
to osmotic gradients. They are distributed 
throughout many tissues, with various known roles 
of production, secretion, reabsorption and regulation 
of water, but also of cell migration (angiogenesis), 
signal transduction, and cell proliferation. There are 
14 AQPs in humans (and 5 pseudogenes): MIP 
(previously called AQP0), AQP1, AQP2, AQP3, 
AQP4, AQP5, AQP6, AQP7, AQP8, AQP9, AQP10, 
AQP11, AQP12A and AQP12B. They are classified 
into two families: orthodox aquaporins, that 
transport water only, and aquaglyceroporins (AQP3, 
AQP7 and AQP9), which also transport glycerol, 
urea and other small molecules. AQPs form homo-
tetramers (Review in Papadopoulos and Saadoun, 
2015). The monomeric units of AQPs are ~30 kDa 
proteins and consist of 6 transmembrane α-helices 
(M1, M2, M4 to M6 and M8), 2 intramembrane half 
helices (M3 and M7), and 5 connecting loops (loops 
A to E) (Review in Verkman et al., 2014). They bear 
conserved intramembrane Asn-Pro-Ala (NPA) 
sequence motifs in the intramembrane domains, and 
six tilted transmembrane helices per monomer, with 
linkers (loops A to E). The NPA motifs act as 
hydrogen-bond donors and acceptors that coordinate 
the transport of water through the pore (Verkman et 
al., 2014). 
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Figure 1. Aquaporin-2 (AQP2) gene exons and protein domains. 
 
Description 
Aquaporin-2 canonical form: 271 aa; 28.837kDa; 
other isoforms; 223, and 244 aa.  
AQP2 is a transmembrane protein, with a N-term 
and a C-term cytoplasmic domains: amino acids 1 - 
16 (Cytoplasmic), 17 - 34 (Transmembrane), 35 - 40 
(Extracellular ("Loop A")), 41 - 59 
(Transmembrane), 60 - 85 (Cytoplasmic ("Loop 
B")), 86 - 107 (Transmembrane), 108 - 127 
(Extracellular ("Loop C")), 128 - 148 
(Transmembrane), 149 - 156 (Cytoplasmic ("Loop 
D")), 157 - 176 (Transmembrane), 177 - 202 
(Extracellular ("Loop E")), 203 - 224 
(Transmembrane), 225 - 271 (Cytoplasmic) (Figure. 
1).  
Helical subunits in Loop B and E juxtapose to form 
a water pore in the monomere. The central pore of 
the homotetramer (Figure. 2) would be a path for ion 
and gas (Review in Huber et al., 2012). 
Remarkable sites:  (Figure. 1)  
NPA: aa 68-70, 184-186 
N-myristoylation sites (role in membrane targeting): 
aa 27-32, 29-34, 49-54, 78-83, 96-101, 128-133, 
175-180, 211-216. 
N-glycosylation sites: aa 123-126. 
Protein kinase C phosphorylation sites: aa 195-197, 
231-233 (Thr 195 and Ser 231); Casein kinase II 
phosphorylation site: aa 108-111 (Thr 108), 148-151 
(Ser 148), 229-232 (Ser 229), 244-247 (Thr 244); 
cAMP-and cGMP-dependent protein kinase (PKA) 
phosphorylation site :aa 253-256. 
 
 
Figure 2.  Aquaporins monomere and tetramere. Aquaporins are transmembrane proteins involved in transport of water and 
small molecules in response to osmotic gradients (water channels). 
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Cell attachment sequence RGD (plays a role in cell 
adhesion): aa 113-115.  
Microbodies C-terminal targeting signal (targeting 
to organelles such as peroxisomes): aa 269-271. 
Expression 
AQPs are widely expressed. AQP2 is mainly 
expressed in the kidney. 
Renal collecting duct principal cells   
Extra-renal localizations:  Ear, epididymis, vas 
deferens, vagina. Both AQP1 and AQP2 are 
expressed in the endometrium. AQP2 endometrial 
expression is menstrual cycle-dependent (high at the 
proliferative and midsecretory phases). 
 
Figure 3. ModBase predicted comparative 3D structure. 
Localisation 
AQP2 undergoes a constitutive recycling: its 
trafficking from intracellular vesicles into the plasma 
membrane and endocytic retrieval to its intracellular 
storage site. AQP2 forms homotetramers in the 
endoplasmic reticulum, passes through the Golgi 
apparatus and is stored in intracellular vesicles in the 
perinuclear region. Under resting conditions, AQP2 
binds monomeric G-actin (ACTG1). F-actin 
destabilization facilitates translocation of AQP2 to 
the apical plasma membrane and water reabsorption 
(Vukićević et al., 2016). 
Function 
AQPs main's role is to maintain tissue water balance. 
AQPs also facilitate cell migration, cell proliferation 
and cell adhesion. Cell migration: AQPs concentrate 
at the leading end of migrating cells and facilitate the 
formation of the lamellipodium (Papadopoulos and 
Saadoun, 2015). Cell proliferation: AQPs may 
activate transduction pathways such as the mitogen-
activated protein kinase pathways or the Wnt/beta-
catenin (CTNNB1) signaling.  
AQP2 key physiological role is water reabsorption 
in collecting duct of the kidney to concentrate urine.  
Vasopressin / vasopressin receptor / aquaporin-2 
axis 
In the kidney, AVP 46535 (vasopressin) binds to 
AVPR2 732 (type 2 vasopressin receptor (V2R)) 
located in the basolateral membrane of the principal 
cells of the collecting ducts and increases osmotic 
water transport through the regulation of the 
aquaporin-2 water channel localized in the kidney 
connecting tubules and collecting ducts. Upon 
binding of vasopressin to AVPR2, the cAMP/PKA 
(PRKAR1A 387) signal is activated, PRKAR1A is 
recruited to the vesicles through PRKAR1A-
anchoring proteins (AKAPs) (AKAP7 46846 co-
localizes with AQP2) and results in phosphorylation 
in the C-terminus of AQP2 at serines 256, 264, and 
269, withdrawing it from F-actin.  
AQP2 is subsequently translocated to the apical 
plasma membrane, and the water luminal 
permeability to increase water reabsorption from 
urine. Vasopressin also triggers increases in 
intracellular calcium required for AQP2 trafficking 
(Reviews in Jung and Kwon 2016; Ando and Uchida 
2018; De Ieso and Yool 2018; Ranieri et al., 2019).  
However, cAMP-independent mechanisms for 
AQP2 trafficking also exist.  
Nuclear receptors, especially PPARG (Peroxisome 
proliferator-activated receptor gamma), NR1H2 
(LXRB, Liver X receptor beta), NR1H4 (FXR, 
Farnesoid X receptor), NR3C1 (GR, Glucocorticoid 
receptor), NR3C2 (MR, Mineralocorticoid receptor) 
and ESR1 (Estrogen receptor alpha) regulate AQP2 
abundance and membrane translocation. PPARG 
induces increased AQP2 expression, sodium and 
water retention and edema. NR3C1 and NR1H4 also 
activate AQP2 expression. NR3C2 and NR1H2 
reduce AQP2 expression. ESR1 mediates the 
inhibitory effect of estradiol on AQP2 expression 
(Zhang et al., 2016).  
 Other factors capable of regulating AQP2: 
extracellular osmotic pressure, insulin (INS), nuclear 
factor kB (NFkB), renin/angiotensin/aldosterone 
system, kinins, nitric oxide, adenosine, ATP and 
endothelins. PTGER2 (Prostaglandin E receptor 2) 
also controls AQP2 expression. The phosphorylated 
activation of CREBBP upregulates AQP2 gene 
transcription (reviewed in Zhang et al., 2016).  
Actin-polymerization/depolymerization  
Actin-depolymerization promotes AQP2 trafficking 
to the plasma membrane. TPM3 and MSN 
(Tropomyosin 3 and Moesin) result in F-actin 
destabilization. MLCK (Myosin light chain kinase) 
also facilitates AQP2 trafficking to the plasma 
membrane by regulating actin filament organization.  
RHOA stimulates actin polymerization, which 
inhibits AQP2 trafficking to the plasma membrane.  
Transcription 
FOSB (FosB proto-oncogene, AP-1 transcription 
factor subunit), CREBBP, calcineurins (protein 
phosphatase 3 subunits) MAPK3 / MAPK1 (so 
called "ERK1/ERK2") and NFAT5 (nuclear factor 
of activated T cells 5) increase AQP2 transcription, 
while NFkB reduces AQP2 gene transcription.  
Endocytosis/ubiquitination/degradation  
FOSB/ TFAP2A (transcription factor AP-2 alpha 
(activating enhancer binding protein 2 alpha)) 
(AP1/AP2) mediates clathrin-mediated endocytosis 
of AQP2.  
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VTA1 (vesicle trafficking 1) facilitates AQP2 
lysosomal degradation. MAPK14 (p38-MAPK) 
phosphorylates AQP2 to induce ubiquitination and 
proteasomal degradation of AQP2. Protein kinases C 
induce ubiquitination, endocytosis and degradation 
of AQP2 (Review in Vuki&cacute;evi&cacute; et 
al., 2016). 
Mutations 
Germinal 
AQP2 is responsible for nephrogenic non-X-linked 
diabetes insipidus, a disease characterized by the 
kidney's inability to concentrate urine (see below). 
Implicated in 
Dysregulation and dysfunction of AQP2 cause many 
disorders related to water balance in humans and 
animals, including polyuria and dilutional 
hyponatremia (Zan et al., 2016).  
Nephrogenic diabetes insipidus. 
Nephrogenic diabetes insipidus is characterized by 
the kidney's inability to concentrate urine even with 
normal or elevated concentration of vasopressin. 
Polyuria/polydipsia and electrolyte imbalance is 
present from birth.  
The antidiuretic peptide hormone arginine-
vasopressin (AVP) is synthesized in the 
hypothalamus. Vasopressin binds its receptor 
AVPR2 (arginine vasopressin receptor 2) in the 
basolateral membrane of cells of the renal collecting 
ducts, inducing the vasopressin / vasopressin 
receptor / aquaporin-2 axis.  
Nephrogenic diabetes insipidus occurs either when:  
AVPR2 is mutated (90% of cases, "X-linked 
nephrogenic diabetes insipidus": AVPR2 locates in 
Xq28), or when  
AQP2 is mutated (10% of cases, "nephrogenic non-
X-linked diabetes insipidus"; both dominant and 
autosomal recessive forms have been reported. 
Patients with recessive forms are either 
homozygous, or compound heterozygous).  
Nephrogenic diabetes insipidus can also be induce 
by lithium, demethylchlortetracycline or other drugs 
(Ranieri et al., 2019). 
Uterus endometrial carcinoma 
There was an increased expression level of AQP2 in 
endometrial carcinoma, in relation to estradiol level. 
AQP2 was mainly located in glandular epithelial 
cells. An estrogen response element was found in the 
promoter of AQP2. In AQP2 knockdown 
endometrial carcinoma cells, there was an alteration 
of the cell morphology by decreasing the expression 
of ANXA2 (Annexin A2) and F-actin (Zou et al., 
2011).  
Glioma 
The expression of both ESR2 (Estrogen Receptor 2 
(ER beta)) and AQP2 was low in glioma cells from 
patient tissues and glioblastoma cell lines.  
AQP2 promoted the transcriptional activity of LAX1 
(Lymphocyte transmembrane adaptor 1) and 
inhibited cell invasion.  
ESR2 may function as AQP2 promoter in the 
nucleus to sustain cells stability while ESRRA 
(Estrogen-related receptor alpha) would acts as an 
antagonist of AQP2 (Wan et al. 2018). 
Kidney adenocarcinomay 
A t(3;12)(p13;q13) AQP2/ FOXP1 has been found 
in adenocarcinoma of the kidney (Hu et al., 2018).  
To be noted 
Aquaporin-targeted drugs:  Heavy metal ions 
(mercury, silver, gold) are inhibitors of aquaporin-1.  
The Henle loop diuretic bumetanide and analogues 
AqB013 and AqF026 also inhibit aquaporin-1.  
The quaternary ammonium compound 
tetraethylammonium is an inhibitor of aquaporin-1 
water permeability (Verkman et al., 2014; Tomita et 
al., 2017). 
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